Investing in Healthcare Innovation

At MPM, we focus equally on capturing and creating value. We capture value by identifying under-appreciated assets and by understanding risk. We "create" value by doing whatever it takes to help our companies succeed.

Latest News

Dec 20, 2011 BV 4 Porfolio Company ForteBio, Inc. Enters Agreement to be Acquired by Pall Corp.

Dec 07, 2011 BV 5 Portfolio Company Aratana Therapeutics Completes $15 Million Series B Financing

Nov 21, 2011 BV 3 Portfolio Company Portola Pharmaceuticals Announces Completion of $89 Million Financing

Oct 31, 2011 BV 4 Portfolio Company Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management

Oct 27, 2011 BV 3 Portfolio Company Portola Pharmaceuticals and Biogen Idec Announce Global Collaboration